Table 1 Clinical characteristics between patients with different treatment protocols
Parameters | ECS (n = 94) | DNV (n = 84) | All (n = 178) | P |
|---|---|---|---|---|
Age, year | 48.88 ± 10.66 | 47.60 ± 10.32 | 48.27 ± 10.49 | 0.417 |
Sex | 0.098 | |||
Male | 66 (70.21%) | 49 (58.33%) | 115 (64.6%) | |
Female | 28 (29.79%) | 35(41.67%) | 63 (35.4%) | |
Comorbidity | 0.054 | |||
No | 80 (85.11%) | 79 (94.05%) | 159 (88.83%) | |
Yes | 14 (14.89%) | 5 (5.95%) | 19 (10.61%) | |
Log10(HCVRNA), log10(IU/mL) | 5.73 ± 1.10 | 6.03 ± 0.96 | 5.89 ± 1.04 | 0.408 |
AFP, ng/mL | 42.84 ± 93.906 | 5.91 ± 5.28 | 21.16 ± 62.79 | 0.012 |
HCV genotype | < 0.001 | |||
1a | 2(2.13%) | 1 (1.19%) | 3 (1.69%) | |
1b | 21 (22.34%) | 41 (48.81%) | 62 (34.83%) | |
2a | 7 (7.45%) | 8 (9.52%) | 15 (8.43%) | |
3a | 7 (7.45%) | 10 (11.90%) | 17 (9.55%) | |
3b | 12 (12.77%) | 10 (11.90%) | 22 (12.36%) | |
6a | 30 (31.91%) | 11 (13.10%) | 41 (23.03%) | |
6e | 1(1.06%) | 0(0.00%) | 1(0.56%) | |
NA | 14(14.89%) | 3(3.57%) | 17(9.55%) | |
Cirrhosis | 0.054 | |||
No | 80(85.11%) | 79 (94.05%) | 159 (89.33%) | |
Yes | 14 (14.89%) | 5(5.95%) | 19 (10.67%) | |
Decompensated cirrhosis | 0.006 | |||
No | 86 (91.49%) | 84 (96.97%) | 170 (95.51%) | |
Yes | 8 (8.51%) | 0 (0) | 8 (4.49%) |